Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC35F2 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC35F2 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SLC35F2 mRNA | CTD | PMID:22206623 | 17beta-estradiol | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Estradiol results in increased expression of SLC35F2 mRNA | CTD | PMID:31614463 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of SLC35F2 mRNA | CTD | PMID:29581250 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC35F2 mRNA | CTD | PMID:21632981 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC35F2 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC35F2 mRNA | CTD | PMID:28922406 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLC35F2 mRNA | CTD | PMID:21570461 and PMID:26377647 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | 3,3',5,5'-tetrabromobisphenol A | increases expression | EXP | | 6480464 | tetrabromobisphenol A results in increased expression of SLC35F2 mRNA | CTD | PMID:25172293 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLC35F2 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLC35F2 mRNA | CTD | PMID:28628672 | 6-propyl-2-thiouracil | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLC35F2 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of SLC35F2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of SLC35F2 mRNA | CTD | PMID:23630614 | all-trans-retinoic acid | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SLC35F2 mRNA | CTD | PMID:21934132 | all-trans-retinoic acid | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of SLC35F2 mRNA | CTD | PMID:23724009 and PMID:33167477 | amitrole | decreases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Amitrole results in decreased expression of SLC35F2 mRNA | CTD | PMID:30047161 | benzo[a]pyrene | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of SLC35F2 mRNA | CTD | PMID:32234424 | bisphenol A | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of SLC35F2 mRNA | CTD | PMID:20678512 | bisphenol A | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC35F2 mRNA | CTD | PMID:25181051 | cadmium atom | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of SLC35F2 mRNA | CTD | PMID:23369406 | caffeine | affects phosphorylation | ISO | SLC35F2 (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SLC35F2 protein | CTD | PMID:35688186 | chlordecone | increases expression | EXP | | 6480464 | Chlordecone results in increased expression of SLC35F2 mRNA | CTD | PMID:33711761 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC35F2 mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SLC35F2 mRNA | CTD | PMID:27392435 | cisplatin | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of SLC35F2 mRNA | CTD | PMID:27392435 | cobalt dichloride | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of SLC35F2 mRNA | CTD | PMID:19320972 | copper(II) sulfate | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SLC35F2 mRNA | CTD | PMID:19549813 | coumarin | decreases phosphorylation | ISO | SLC35F2 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of SLC35F2 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLC35F2 mRNA | CTD | PMID:20106945 and PMID:25562108 | cyclosporin A | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SLC35F2 mRNA | CTD | PMID:27989131 | deguelin | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | deguelin results in increased expression of SLC35F2 mRNA | CTD | PMID:33512557 | dexamethasone | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLC35F2 mRNA | CTD | PMID:28628672 | diquat | decreases expression | EXP | | 6480464 | Diquat results in decreased expression of SLC35F2 protein | CTD | PMID:36851058 | dorsomorphin | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLC35F2 mRNA | CTD | PMID:29803840 | etoposide | decreases expression | EXP | | 6480464 | Etoposide results in decreased expression of SLC35F2 mRNA | CTD | PMID:25270620 | flutamide | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of SLC35F2 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC35F2 mRNA | CTD | PMID:20938992 | gentamycin | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of SLC35F2 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of SLC35F2 mRNA | CTD | PMID:20044591 | indometacin | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of SLC35F2 mRNA | CTD | PMID:28628672 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC35F2 mRNA | CTD | PMID:36331819 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC35F2 mRNA | CTD | PMID:20938992 | lead diacetate | decreases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | lead acetate results in decreased expression of SLC35F2 mRNA | CTD | PMID:22641619 | methimazole | decreases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Methimazole results in decreased expression of SLC35F2 mRNA | CTD | PMID:30047161 | methyl methanesulfonate | decreases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of SLC35F2 mRNA | CTD | PMID:23649840 | orphenadrine | affects expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Orphenadrine affects the expression of SLC35F2 mRNA | CTD | PMID:23665939 | panobinostat | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35F2 mRNA | CTD | PMID:27188386 | panobinostat | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | panobinostat results in increased expression of SLC35F2 mRNA | CTD | PMID:26272509 | perfluorononanoic acid | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in increased expression of SLC35F2 mRNA | CTD | PMID:33483757 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in increased expression of SLC35F2 mRNA more ... | CTD | PMID:33483757 and PMID:36331819 | phenylmercury acetate | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of SLC35F2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35F2 mRNA | CTD | PMID:27188386 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SLC35F2 mRNA | CTD | PMID:18301758 and PMID:23811191 | potassium chromate | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of SLC35F2 mRNA | CTD | PMID:22714537 | pyrimidifen | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | pyrimidifen results in increased expression of SLC35F2 mRNA | CTD | PMID:33512557 | rotenone | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Rotenone results in increased expression of SLC35F2 mRNA | CTD | PMID:33512557 | SB 431542 | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sulfadimethoxine | decreases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in decreased expression of SLC35F2 mRNA | CTD | PMID:30047161 | tert-butyl hydroperoxide | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in increased expression of SLC35F2 mRNA | CTD | PMID:15336504 | tetrachloromethane | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of SLC35F2 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of SLC35F2 mRNA] | CTD | PMID:31150632 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC35F2 mRNA | CTD | PMID:25549359 | trichostatin A | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of SLC35F2 mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35F2 mRNA | CTD | PMID:27188386 | triclosan | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Triclosan results in increased expression of SLC35F2 mRNA | CTD | PMID:30510588 | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of SLC35F2 mRNA | CTD | PMID:19042947 | valproic acid | affects expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SLC35F2 mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | SLC35F2 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC35F2 mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC35F2 mRNA | CTD | PMID:23179753 more ... | vinclozolin | increases expression | ISO | Slc35f2 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of SLC35F2 mRNA | CTD | PMID:23869203 | zidovudine | increases expression | ISO | SLC35F2 (Homo sapiens) | 6480464 | Zidovudine results in increased expression of SLC35F2 mRNA | CTD | PMID:24292225 | |